Literature DB >> 19576624

WNT/TCF signaling through LEF1 and HOXB9 mediates lung adenocarcinoma metastasis.

Don X Nguyen1, Anne C Chiang, Xiang H-F Zhang, Juliet Y Kim, Mark G Kris, Marc Ladanyi, William L Gerald, Joan Massagué.   

Abstract

Metastasis from lung adenocarcinoma can occur swiftly to multiple organs within months of diagnosis. The mechanisms that confer this rapid metastatic capacity to lung tumors are unknown. Activation of the canonical WNT/TCF pathway is identified here as a determinant of metastasis to brain and bone during lung adenocarcinoma progression. Gene expression signatures denoting WNT/TCF activation are associated with relapse to multiple organs in primary lung adenocarcinoma. Metastatic subpopulations isolated from independent lymph node-derived lung adenocarcinoma cell lines harbor a hyperactive WNT/TCF pathway. Reduction of TCF activity in these cells attenuates their ability to form brain and bone metastases in mice, independently of effects on tumor growth in the lungs. The WNT/TCF target genes HOXB9 and LEF1 are identified as mediators of chemotactic invasion and colony outgrowth. Thus, a distinct WNT/TCF signaling program through LEF1 and HOXB9 enhances the competence of lung adenocarcinoma cells to colonize the bones and the brain. For a video summary of this article, see the PaperFlick file available with the online Supplemental Data.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19576624      PMCID: PMC2742946          DOI: 10.1016/j.cell.2009.04.030

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  58 in total

Review 1.  Controlling cell fate by bone morphogenetic protein receptors.

Authors:  Peter ten Dijke; Olexander Korchynskyi; Gudrun Valdimarsdottir; Marie-José Goumans
Journal:  Mol Cell Endocrinol       Date:  2003-12-15       Impact factor: 4.102

Review 2.  The Wnt signaling pathway in development and disease.

Authors:  Catriona Y Logan; Roel Nusse
Journal:  Annu Rev Cell Dev Biol       Date:  2004       Impact factor: 13.827

3.  Sites of recurrence in resected stage I non-small-cell lung cancer: a guide for future studies.

Authors:  R Feld; L V Rubinstein; T H Weisenberger
Journal:  J Clin Oncol       Date:  1984-12       Impact factor: 44.544

4.  Incidence and possible clinical significance of K-ras oncogene activation in adenocarcinoma of the human lung.

Authors:  S Rodenhuis; R J Slebos; A J Boot; S G Evers; W J Mooi; S S Wagenaar; P C van Bodegom; J L Bos
Journal:  Cancer Res       Date:  1988-10-15       Impact factor: 12.701

5.  NCI-Navy Medical Oncology Branch cell line data base.

Authors:  R M Phelps; B E Johnson; D C Ihde; A F Gazdar; D P Carbone; P R McClintock; R I Linnoila; M J Matthews; P A Bunn; D Carney; J D Minna; J L Mulshine
Journal:  J Cell Biochem Suppl       Date:  1996

6.  Prediction of the antitumor activity of new platinum analogs based on their ex vivo pharmacodynamics as determined by bioassay.

Authors:  Y Sasaki; T Shinkai; K Eguchi; T Tamura; Y Ohe; T Ohmori; N Saijo
Journal:  Cancer Chemother Pharmacol       Date:  1991       Impact factor: 3.333

Review 7.  WNT and beta-catenin signalling: diseases and therapies.

Authors:  Randall T Moon; Aimee D Kohn; Giancarlo V De Ferrari; Ajamete Kaykas
Journal:  Nat Rev Genet       Date:  2004-09       Impact factor: 53.242

8.  Incidence of local recurrence and second primary tumors in resected stage I lung cancer.

Authors:  N Martini; M S Bains; M E Burt; M F Zakowski; P McCormack; V W Rusch; R J Ginsberg
Journal:  J Thorac Cardiovasc Surg       Date:  1995-01       Impact factor: 5.209

9.  Distinct molecular forms of beta-catenin are targeted to adhesive or transcriptional complexes.

Authors:  Cara J Gottardi; Barry M Gumbiner
Journal:  J Cell Biol       Date:  2004-10-18       Impact factor: 10.539

10.  An integrated genomic analysis of lung cancer reveals loss of DUSP4 in EGFR-mutant tumors.

Authors:  D Chitale; Y Gong; B S Taylor; S Broderick; C Brennan; R Somwar; B Golas; L Wang; N Motoi; J Szoke; J M Reinersman; J Major; C Sander; V E Seshan; M F Zakowski; V Rusch; W Pao; W Gerald; M Ladanyi
Journal:  Oncogene       Date:  2009-06-15       Impact factor: 9.867

View more
  290 in total

1.  p53 and microRNA-34 are suppressors of canonical Wnt signaling.

Authors:  Nam Hee Kim; Hyun Sil Kim; Nam-Gyun Kim; Inhan Lee; Hyung-Seok Choi; Xiao-Yan Li; Shi Eun Kang; So Young Cha; Joo Kyung Ryu; Jung Min Na; Changbum Park; Kunhong Kim; Sanghyuk Lee; Barry M Gumbiner; Jong In Yook; Stephen J Weiss
Journal:  Sci Signal       Date:  2011-11-01       Impact factor: 8.192

2.  Integrative genomic and proteomic analyses identify targets for Lkb1-deficient metastatic lung tumors.

Authors:  Julian Carretero; Takeshi Shimamura; Klarisa Rikova; Autumn L Jackson; Matthew D Wilkerson; Christa L Borgman; Matthew S Buttarazzi; Benjamin A Sanofsky; Kate L McNamara; Kathleyn A Brandstetter; Zandra E Walton; Ting-Lei Gu; Jeffrey C Silva; Katherine Crosby; Geoffrey I Shapiro; Sauveur-Michel Maira; Hongbin Ji; Diego H Castrillon; Carla F Kim; Carlos García-Echeverría; Nabeel Bardeesy; Norman E Sharpless; Neil D Hayes; William Y Kim; Jeffrey A Engelman; Kwok-Kin Wong
Journal:  Cancer Cell       Date:  2010-06-15       Impact factor: 31.743

Review 3.  Modeling metastasis in the mouse.

Authors:  Paula D Bos; Don X Nguyen; Joan Massagué
Journal:  Curr Opin Pharmacol       Date:  2010-07-01       Impact factor: 5.547

4.  Comprehensive analysis of the homeobox family genes in breast cancer demonstrates their similar roles in cancer and development.

Authors:  Ayako Nakashoji; Tetsu Hayashida; Shigeo Yamaguchi; Yuko Kawai; Masayuki Kikuchi; Takamichi Yokoe; Aiko Nagayama; Tomoko Seki; Maiko Takahashi; Yuko Kitagawa
Journal:  Breast Cancer Res Treat       Date:  2021-01-18       Impact factor: 4.872

5.  Serpins promote cancer cell survival and vascular co-option in brain metastasis.

Authors:  Manuel Valiente; Anna C Obenauf; Xin Jin; Qing Chen; Xiang H-F Zhang; Derek J Lee; Jamie E Chaft; Mark G Kris; Jason T Huse; Edi Brogi; Joan Massagué
Journal:  Cell       Date:  2014-02-27       Impact factor: 41.582

6.  Histone demethylase RBP2 is critical for breast cancer progression and metastasis.

Authors:  Jian Cao; Zongzhi Liu; William K C Cheung; Minghui Zhao; Sophia Y Chen; Siew Wee Chan; Carmen J Booth; Don X Nguyen; Qin Yan
Journal:  Cell Rep       Date:  2014-02-27       Impact factor: 9.423

Review 7.  In vivo animal models for studying brain metastasis: value and limitations.

Authors:  Inderjit Daphu; Terje Sundstrøm; Sindre Horn; Peter C Huszthy; Simone P Niclou; Per Ø Sakariassen; Heike Immervoll; Hrvoje Miletic; Rolf Bjerkvig; Frits Thorsen
Journal:  Clin Exp Metastasis       Date:  2013-01-16       Impact factor: 5.150

Review 8.  The way Wnt works: components and mechanism.

Authors:  Kenyi Saito-Diaz; Tony W Chen; Xiaoxi Wang; Curtis A Thorne; Heather A Wallace; Andrea Page-McCaw; Ethan Lee
Journal:  Growth Factors       Date:  2012-12-21       Impact factor: 2.511

Review 9.  WNT signalling pathways as therapeutic targets in cancer.

Authors:  Jamie N Anastas; Randall T Moon
Journal:  Nat Rev Cancer       Date:  2013-01       Impact factor: 60.716

10.  Role of DAB2IP in modulating epithelial-to-mesenchymal transition and prostate cancer metastasis.

Authors:  Daxing Xie; Crystal Gore; Jun Liu; Rey-Chen Pong; Ralph Mason; Guiyang Hao; Michael Long; Wareef Kabbani; Luyang Yu; Haifeng Zhang; Hong Chen; Xiankai Sun; David A Boothman; Wang Min; Jer-Tsong Hsieh
Journal:  Proc Natl Acad Sci U S A       Date:  2010-01-13       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.